Health ❯ Healthcare

Research and Development

Clinical Trials Clinical Research Drug Development Pharmaceuticals Biotechnology Medical Innovations Innovative Therapies Innovative Treatments Gene Therapy Clinical Studies

LEO Pharma to Acquire Replay in $50 Million Gene-Therapy Deal

The move underscores LEO’s effort to show a growth path ahead of a potential stock-market listing.

FDA Grants Orphan Drug Status to Immutep’s Efti for Soft Tissue Sarcoma

Brazil Sets Deal to Produce Cancer Immunotherapy for the Public Health System

Sarepta Reports Early siRNA Data Showing Muscle Delivery as Shares Surge

Delhi Plans AIIMS-Style Merger of GTB, DSCI and RGSSH to Expand Medical Training

Milan’s Besta Hospital Deploys Rare Exablate Prime to Speed MRI‑Guided Brain Ultrasound

Eli Lilly’s Tirzepatide Surge Collides With Rich-Valuation Concerns

Driehaus and Deerfield Lift Praxis Stakes in Q4, SEC Filings Show

Abbott to Commercialize Novo Nordisk’s Semaglutide in India Under Extensior Brand

Spanish Hospitals Mark Cochlear Implant Milestones as Care Expands to Remote Follow‑Up

Merck and Mayo Clinic Launch AI Drug Discovery Collaboration Using Platform_Orchestrate

FDA Grants Breakthrough Therapy Designation to Biogen’s Litifilimab for Cutaneous Lupus

Novartis Licenses SciNeuro’s Brain‑Shuttle Alzheimer’s Antibodies in Deal Worth Up to $1.7 Billion

FDA Issues Second Rejection of Atara’s EBV+ PTLD Therapy Tabelecleucel

Aktis Oncology Soars 24% in Nasdaq Debut After $318 Million IPO

Kyverna CAR-T Delivers Positive Phase 2 Topline in Stiff Person Syndrome as Shares Jump

Belite Bio’s Tinlarebant Cuts Stargardt Lesion Growth 36% in Phase 3 Trial

NICE Backs Obe-cel for Adults With Aggressive Leukaemia as NHS Fast-Tracks Rollout

Vaccimel, Argentina's Melanoma Immunotherapy, Enters Commercial Use

Moderna Secures $1.5 Billion Loan, Outlines Path to 2028 Breakeven